ATP3 WomenLoading...Age20-34-735-39-340-44045-49+350-54+655-59+860-64+1065-69+1270-74+1475-79+16Tot Chol<160 (4.1) & Age 20-790160-199 (4.1-5.3) & Age 60-69+1160-199 (4.1-5.3) & Age 70-79+1200-239 (5.3-6.2) & Age 70-79+1160-199 (4.1-5.3) & Age 50-59+2200-239 (5.3-6.2) & Age 60-69+2240-279 (6.2-7.3) & Age 70-79+2280+ (7.3+) & Age 70-79+2160-199 (4.1-5.3) & Age 40-49+3240-279 (6.2-7.3) & Age 60-69+3160-199 (4.1-5.3) & Age 20-39+4200-239 (5.3-6.2) & Age 50-59+4280+ (7.3+) & Age 60-69+4240-279 (6.2-7.3) & Age 50-59+5200-239 (5.3-6.2) & Age 40-49+6280+ (7.3+) & Age 50-59+7200-239 (5.3-6.2) & Age 20-39+8240-279 (6.2-7.3) & Age 40-49+8280+ (7.3+) & Age 40-49+10240-279 (6.2-7.3) & Age 20-39+11280+ (7.3+) & Age 20-39+13SmokerNonsmoker & Age 20-790Smoker & Age 70-79+1Smoker & Age 60-79+2Smoker & Age 50-59+4Smoker & Age 40-49+7Smoker & Age 20-39+9HDL60+ (1.6+)-150-59 (1.3-1.6)040-49 (1.0-1.3)+1<40 (1.0)+2Syst BP<1200120-129 & Untreated+1130-139 & Untreated+2120-129 & Treated+3140-159 & Untreated+3130-139 & Treated+4160+ & Untreated+4140-159 & Treated+5160+ & Treated+6Indications d'utilisationInformations et précautions